Characterizing immunocompetent models of PSMA plus prostate cancer to investigate [225Ac]Ac-PSMA-617 efficacy in mice

被引：0
|
作者：
Taddio, Marco [1 ]
Rodriguez, Arely Perez [2 ]
Azrour, Ines [1 ]
Richard, Mathis [1 ]
Vilangattil, Meryl [1 ]
Jeanjean, Pauline [3 ]
Besserer-Offroy, Elie [4 ]
Carlucci, Giuseppe [1 ]
Czernin, Johannes [1 ]
Mona, Christine [1 ]
机构：
[1] Univ Calif Los Angeles, Ahmanson Translat Theranost Div, Pharmacol, Los Angeles, CA USA
[2] UCLA, Ahmanson Translat Theranost Div, Pharmacol, Los Angeles, CA USA
[3] UCLA, Los Angeles, CA USA
[4] Univ Calif Los Angeles, Ahmanson Translat Theranost Div, Los Angeles, CA USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P1216
引用
收藏
页数：3
相关论文
共 50 条
  • [1] [225Ac]Ac-SibuDAB for Targeted Alpha Therapy of Prostate Cancer: Preclinical Evaluation and Comparison with [225Ac]Ac-PSMA-617
    Busslinger, Sarah D.
    Tschan, Viviane J.
    Richard, Olivia K.
    Talip, Zeynep
    Schibli, Roger
    Mueller, Cristina
    CANCERS, 2022, 14 (22)
  • [2] Radiolabeling of [225Ac]Ac-PSMA-617 vs [225Ac]Ac-DOTATATE: What Analogies? What Differences?
    Esposito, A.
    Aurilio, M.
    Buonanno, M.
    Morisco, A.
    Maisto, C.
    D'Ambrosio, L.
    Di Martino, D.
    Lastoria, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S782 - S783
  • [3] [225Ac]Ac-PSMA-617 Targeted Alpha Therapy in Metastatic Castration-Resistant Prostate Cancer: efficacy and treatment outcome
    Ebrahimifard, A.
    Bagheri, S.
    Wang, Q.
    Eilsberger, F.
    Luster, M.
    Librizzi, D.
    Yousefi, B. H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S360 - S360
  • [4] [225Ac]Ac-PSMA-617 augmented [177Lu]Lu-PSMA-617 RLT in challenging advanced mCRPC patients
    Rosar, F.
    Krause, J.
    Bartholomae, M.
    Maus, S.
    Stemler, T.
    Hierlmeier, I.
    Linxweiler, J.
    Ezziddin, S.
    Khreish, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S315 - S315
  • [5] AcTION: A phase 1 study of [225Ac]Ac-PSMA-617 in men with PSMA-positive prostate cancer with or without prior [177Lu]Lu-PSMA-617 radioligand therapy
    Sathekge, M.
    Crumbaker, M.
    Joshua, A. M.
    Bruchertseifer, F.
    Kreisl, T.
    Emineni, S.
    Wehbe, J.
    Korn, M.
    Morgenstern, A.
    Emmett, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S152 - S153
  • [6] Hematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer
    Lawal, Ismaheel O.
    Morgenstern, Alfred
    Vorster, Mariza
    Knoesen, Otto
    Mahapane, Johncy
    Hlongwa, Khanyisile N.
    Maserumule, Letjie C.
    Ndlovu, Honest
    Reed, Janet D.
    Popoola, Gbenga O.
    Mokoala, Kgomotso M. G.
    Mdlophane, Amanda
    Bruchertseifer, Frank
    Sathekge, Mike M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (10) : 3581 - 3592
  • [7] Hematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer
    Ismaheel O. Lawal
    Alfred Morgenstern
    Mariza Vorster
    Otto Knoesen
    Johncy Mahapane
    Khanyisile N. Hlongwa
    Letjie C. Maserumule
    Honest Ndlovu
    Janet D. Reed
    Gbenga O. Popoola
    Kgomotso M. G. Mokoala
    Amanda Mdlophane
    Frank Bruchertseifer
    Mike M. Sathekge
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 3581 - 3592
  • [8] Efficacy and Safety of [225Ac]Ac-PSMA-617 Augmented [177Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Highly Advanced mCRPC with Poor Prognosis
    Rosar, Florian
    Krause, Jonas
    Bartholoma, Mark
    Maus, Stephan
    Stemler, Tobias
    Hierlmeier, Ina
    Linxweiler, Johannes
    Ezziddin, Samer
    Khreish, Fadi
    PHARMACEUTICS, 2021, 13 (05)
  • [9] 225Ac-PSMA-617 for Therapy of Prostate Cancer
    Kratochwil, Clemens
    Haberkorn, Uwe
    Giesel, Frederik Lars
    SEMINARS IN NUCLEAR MEDICINE, 2020, 50 (02) : 133 - 140
  • [10] Deescalated 225 Ac-PSMA-617 Versus 177 Lu/ 225 Ac-PSMA-617 Cocktail Therapy: A Single-Center Retrospective Analysis of 233 Patients
    Rathke, Hendrik
    Winter, Erik
    Bruchertseifer, Frank
    Roehrich, Manuel
    Giesel, Frederik Lars
    Haberkorn, Uwe
    Morgenstern, Alfred
    Kratochwil, Clemens
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (07) : 1057 - 1063
12345